Aclarion (NASDAQ:ACON – Get Free Report) will likely be posting its quarterly earnings results before the market opens on Thursday, March 27th. Analysts expect Aclarion to post earnings of ($50.00) per share and revenue of $0.02 million for the quarter.
Aclarion Price Performance
Shares of Aclarion stock opened at $0.76 on Thursday. Aclarion has a 52 week low of $0.61 and a 52 week high of $231.15. The business has a 50 day moving average price of $2.84 and a 200-day moving average price of $38.40.
Wall Street Analysts Forecast Growth
Several equities analysts have recently issued reports on the company. Maxim Group reaffirmed a “hold” rating on shares of Aclarion in a report on Friday, December 13th. Ascendiant Capital Markets reduced their target price on Aclarion from $502.50 to $435.50 and set a “buy” rating for the company in a report on Wednesday, November 27th.
Aclarion Company Profile
Aclarion, Inc, a healthcare technology company, leverages for Magnetic Resonance Spectroscopy (MRS) in the United States. It develops NOCISCAN Post-Processor suite of software applications comprising NOCICALC that receives the raw un-processed NOCISCAN MRS exam data and post-processes that raw data into final spectra and performs various degenerative pain biomarker; and NOCIGRAM, a clinical decision support software.
Featured Stories
- Five stocks we like better than Aclarion
- How to Profit From Growth Investing
- What GTC 2025 Signals for NVIDIA Stock’s Next Big Move
- Ride Out The Recession With These Dividend Kings
- Alphabet’s Officially In A Bear Market—Time To Buy?
- What Does a Gap Up Mean in Stocks? How to Play the Gap
- D-Wave and Quantum Supremacy: Implications For Investors
Receive News & Ratings for Aclarion Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aclarion and related companies with MarketBeat.com's FREE daily email newsletter.
